Kane Biotech Inc. Insider Trading

Kane Biotech is a Canadian biotechnology company focused on researching, developing, and commercializing technologies and products designed to prevent and remove microbial biofilms. The company operates in both domestic and international markets. Its work is built around two core technologies: coactiv+, a biofilm destabilizing formula with continuous activity, and DispersinB, a naturally occurring enzyme that targets a bacterial surface polysaccharide called PNAG, with applications in wound care and otic infections.

The company’s wound care portfolio includes products sold under the revyve brand, such as an antimicrobial wound gel, antimicrobial wound gel spray, and antimicrobial wound rinse. It also markets an antimicrobial surgical hydrogel under the coactiv+ name. Beyond wound care, Kane Biotech offers a scalp detoxifier product line through its Omni Bioceuticals brand.

Products currently in development include a coactiv+ Antimicrobial Surgical Hydrogel for surgical and acute wounds, a revyve Antimicrobial Wound Rinse for acute and chronic wounds, a DispersinB Hydrogel for surgical and acute wounds, and a DispersinB Acne Cleanser targeting mild to moderate acne vulgaris. The company is headquartered in Winnipeg, Canada.